Specifically, two reports have supported the role of NR4A1 as a tumor suppressor in hematologic and breast cancer [46, 47], while a third report proposed its role in potentiating TGF-β signaling and promoting metastasis in breast cancer [48]. The gene discussed is NR4A1; the disease is breast cancer.